» Articles » PMID: 35323618

Higher Levels of Stress-Related Hair Steroid Hormones Are Associated with the Increased SCORE2 Risk Prediction Algorithm in Apparently Healthy Women

Abstract

Cardiovascular diseases (CVDs) are the major cause of death worldwide. Although the importance of conventional CVD risk factors, including older age, male gender, hypertension, obesity, dyslipidemia and hyperglycemia, is well-studied, psychosocial stress, which is considered an independent CVD risk factor, requires further investigation. Thus, we aimed to investigate the association between long-term secretion of stress-related steroid hormones, including cortisol, cortisone and dehydroepiandrosterone, and the 10-year fatal and non-fatal CVD risk estimated by the SCORE2 risk prediction algorithm, as well as traditional CVD risk factors in a group of apparently healthy women. A total of 145 women (aged 50-64 years) participating in the national CVD prevention program were enrolled in the study. Sociodemographic, lifestyle, health-related characteristics, stress, anxiety and sleep quality indicators were evaluated using specific questionnaires. Anthropometric and arterial blood pressure measures were assessed by trained personnel, lipid and glucose metabolism biomarkers were measured using routine methods, and hair steroid hormone levels were determined by ultra-high-performance liquid chromatography-tandem mass spectrometry. The results showed that higher levels of hair cortisol and cortisone are associated with increased SCORE2 values. Moreover, significant associations between hair glucocorticoids and individual cardiovascular risk factors, including obesity, hypertension, dyslipidemia and hyperglycemia, were found. These findings indicate that stress-related hair steroid hormones might be valuable biomarkers for CVD prediction and prevention.

Citing Articles

Atherosclerotic Cardiovascular Disease: Risk Assessment, Prevention and Treatment Strategies.

Jeras J, Ugovsek S, Rehberger Likozar A, Sebestjen M J Cardiovasc Dev Dis. 2022; 9(12).

PMID: 36547456 PMC: 9781134. DOI: 10.3390/jcdd9120460.

References
1.
Visseren F, Mach F, Smulders Y, Carballo D, Koskinas K, Back M . 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021; 42(34):3227-3337. DOI: 10.1093/eurheartj/ehab484. View

2.
Wester V, Noppe G, Savas M, van den Akker E, de Rijke Y, van Rossum E . Hair analysis reveals subtle HPA axis suppression associated with use of local corticosteroids: The Lifelines cohort study. Psychoneuroendocrinology. 2017; 80:1-6. DOI: 10.1016/j.psyneuen.2017.02.024. View

3.
Van Uum S, Sauve B, FRASER L, Morley-Forster P, Paul T, Koren G . Elevated content of cortisol in hair of patients with severe chronic pain: a novel biomarker for stress. Stress. 2008; 11(6):483-8. DOI: 10.1080/10253890801887388. View

4.
Nafisa A, Wattoo F, Qayyum M, Gulfraz M . The association between chronic stress, hair cortisol, and angiographically documented coronary atherosclerosis, a case-control study. Stress. 2021; 24(6):1008-1015. DOI: 10.1080/10253890.2021.1985994. View

5.
Wang C, Dai J, Li J . Mediating effects of hair cortisol on the mutual association of job burnout and insomnia: A retrospective exploratory study. J Psychiatr Res. 2019; 117:62-67. DOI: 10.1016/j.jpsychires.2019.07.001. View